Sanuwave confirms acting CEO Richardson as company head | Personnel Moves – December 12, 2018

Sanuwave said late last month that it lifted acting CEO and board chair Kevin Richardson to a permanent position in the corner office. Richardson joined the Suwanee, Ga.-based company in 2009 as board chair, and has served as acting CEO since 2014. He also served as managing partner of investment management firm Prides Capital from 2004 to September 2018. Sanuwave said that Richardson took over as the permanent CEO as of November 30, and that he will continue to serve as board chair alongside his new position heading the company, according to an SEC filing.  Common Sensing lifts Schmid to CEO, White to board chair Common Sensing said late last month it lifted COO and board member Kevin Schmid to the role of CEO, and that it appointed co-founder James White as its board chair. Prior to joining Common Sensing, Schmid held “pivotal roles” at Insulet (NSDQ:PODD), Bose, JDS Uniphase and the Stevanato Group and served as a board member for Sorrel Medical. “Kevin’s appointment to the chief executive role puts Common Sensing in a very strong position to scale Gocap injector monitoring platforms for insulin and beyond. As we transition from pilot level to commercial level operations over the next year, Kevin’s transformative leadership of the talented and growing Common Sensing team will evolve and drive the execution of our go-to-market strategies for our patented dose sensing technology. Our goal is to provide a smart dose sensing platform for patient...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Featured Bose Corp. Bristol-Myers Squibb Co. Common Sensing glympsebio INSIGHTEC Insulet IsoRay Merck novadipbiosciences owensminor rmsmedical Sanuwave Visioneering Technologies Zimmer Biomet Source Type: news